The outcome affirm conclusions drawn by Bagli et al. [1], who performed a review that integrated 10 patients diagnosed with CRAO who been given HBOT. As well as obtaining 20 classes of HBOT, oral acetazolamide and topical beta-blockers had been administered for the patients in the earliest feasible time.OPDIVO® (nivolumab) is really a prescription